FibroBiologics Inc

NAS:FBLGHealthcarenasdaq_composite

$0.9710−2.90%At closeAt close · Sat 17 Oct · ≈ AED 3.57 · Market cap $6.47M · Next earnings Fri 30 Oct

USD millions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Revenue	0.0	0.0	0.0	0.0	0.0	0.0	0.0	—
Cost of revenue	0.0	0.0	0.0	0.0	0.0	0.8	0.6	−24.8%
Gross profit	0.0	0.0	0.0	0.0	0.0	(0.8)	(0.6)	+24.8%
Research & development	0.7	0.5	1.1	2.4	4.5	7.4	8.2	+10.7%
Selling, general & administrative	0.5	1.1	3.3	6.5	9.2	9.2	—	—
Selling & marketing	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Operating expenses	1.2	1.6	4.5	8.9	13.7	15.8	16.7	+5.8%
Operating income	(1.2)	(1.6)	(4.5)	(8.9)	(13.7)	(16.6)	(16.7)	−0.5%
Interest expense	0.0	0.0	0.7	0.1	0.0	0.2	0.2	+5.4%
Interest income	0.0	0.0	0.0	0.0	0.3	0.2	0.1	−46.2%
Other income / expense	0.0	(0.0)	(0.7)	(7.6)	2.6	(2.0)	—	—
Pre-tax income	(1.2)	(1.6)	(5.1)	(16.5)	(11.2)	(18.6)	(18.1)	+2.7%
Income tax	0.0	0.0	0.0	0.0	0.0	0.0	0.0	—
Net income	(1.2)	(1.6)	(5.1)	(16.5)	(11.2)	(18.6)	(18.1)	+2.7%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—	—
EPS, basic (per share)	(0.72)	(0.97)	(3.20)	(11.80)	(6.80)	(8.40)	(4.01)	+52.3%
EPS, diluted (per share)	(0.72)	(0.97)	(3.20)	(11.80)	(6.80)	(8.40)	(4.01)	+52.3%
EBITDA	0.0	(1.6)	(4.4)	(15.9)	(10.6)	(17.6)	(16.2)	+7.9%
Depreciation & amortization	1.2	0.0	0.1	0.4	0.6	0.8	0.4	−47.8%
Weighted average shares (shares)	1,624,603	1,623,860	1,623,860	1,624,603	1,643,754	2,233,026	—	—
Weighted average diluted shares (shares)	1,624,603	1,623,860	1,623,860	1,624,603	1,643,754	2,233,026	—	—

USD millionsUpdated Fri 31 Jul ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.